Coronavirus update: Trump signs $8.3B spending bill into law; Pfizer considers mRNA vaccine pact with BioNTech
→ As the global case count of infections attributed to the new coronavirus climbed to 100,000 and the WHO urged global leaders to pull out all the stops, US President Donald Trump signed into law an $8.3 billion emergency spending bill to confront the outbreak.
→ After revealing at a White House meeting that it’s screening an in-house antiviral library for a potential covid-19 treatment, Pfizer told Reuters it is considering working with BioNTech on an mRNA vaccine. The two companies are already allied on a flu vaccine program.
→ Mount Sinai Health System and Harbour BioMed are joining the hunt for antibodies against the new coronavirus, combining the New York-based institution’s clinical network and the Dutch company’s mice platform.